• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AGX:GR

0.048 EUR 0.002 4.00%

As of 03:15:21 ET on 04/23/2014.

Snapshot for Agennix AG (AGX)

Open: 0.037 Day's Range: 0.037 - 0.061 Volume: 0
Previous Close: 0.050 52wk Range: 0.003 - 0.298 1-Yr Rtn: -73.33%

Stock Chart for AGX

No chart data available.
  • AGX:GR 0.048
  • 1D
  • 1M
  • 1Y
0.050
Interactive AGX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AGX

Current P/E Ratio (ttm) -
Estimated P/E(12/2012) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -2.5500
Est. EPS (EUR) (12/2012) -
Est. PEG Ratio -
Market Cap (M EUR) 2.56
Shares Outstanding (M) 51.27
30 Day Average Volume 18,964
Price/Book (mrq) 0.0786
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AGX

No data available

Company Profile & Key Executives for AGX

Agennix AG is a biopharmaceutical company. The Company researches and develops cancer therapies.

Torsten HombeckSpeaker/Senior VP/CFO-Mgmt BdRajesh K MalikSenior VP/Chief Medical Officer
Colin FreundSenior VP/Chief Business OfficerChristine BoisclairSr VP:Global Regulatory Affairs
More Company Profile & Key Executives for AGX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil